(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. In S2 cells, Abl promotes actin accumulation while Cta promotes myosin
accumulation. S2 cells are shown, and the antigens, transfections and RNAi
treatments are indicated. (A) UAS-Abl::GFP fusion construct.
(B-E''') Transfected cells. Arrows indicate UAS-Abl overexpressing
cells in B,C; UAS-activated Cta in D; and UAS-activated Rho in E. Arrowheads
indicate untransfected controls. Abl-transfected cells display elevated
phosphorylated Tyr (P-Tyr; B') and concentrated actin, but show no
change in Myo-P (P-Myo) expression (C). (D) Cta-transfected cells
display concentrated P-Myo, but not actin. (E) Rho-transfected cells exhibit
concentrated actin and P-Myo, which are organized into a central ring.
(F-H') abl RNAi does not block Rho gain-of-function. (F)
Control RNAi. (G,G') Control RNAi+active Rho. Notice increased Rho and
concentrated actin relative to F,F'. (H,H') abl
RNAi+active Rho. Rho and actin localization is similar to active Rho alone
(G,G'). (I) Immunoblot showing knockdown of the Abl protein from
the S2 cells shown in G-H'. Samples were non-adjacent on the same gel.
Pnut, loading control; PTyr, Phospho-Tyrosine. Scale bar: 30 µm.